| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/03/2023 | 12.5% | Mizuho | → $134 | Initiates Coverage On | → Buy |
| 09/14/2023 | 41.89% | RBC Capital | → $169 | Reiterates | Outperform → Outperform |
| 09/06/2023 | 41.05% | RBC Capital | $180 → $168 | Maintains | Outperform |
| 05/09/2023 | 39.37% | Argus Research | $175 → $166 | Maintains | Buy |
| 04/27/2023 | 30.97% | Wells Fargo | $154 → $156 | Maintains | Equal-Weight |
| 04/24/2023 | 17.54% | B of A Securities | $134 → $140 | Maintains | Underperform |
| 03/07/2023 | 51.12% | RBC Capital | → $180 | Reiterates | → Outperform |
| 02/17/2023 | 29.29% | UBS | $164 → $154 | Maintains | Neutral |
| 02/16/2023 | 31.81% | CFRA | $152 → $157 | Maintains | Hold |
| 11/02/2022 | 25.09% | Wells Fargo | $140 → $149 | Maintains | Equal-Weight |
| 11/01/2022 | 55.32% | Janney Montgomery Scott | $183 → $185 | Maintains | Buy |
| 11/01/2022 | 26.77% | UBS | $130 → $151 | Maintains | Neutral |
| 10/20/2022 | 17.54% | Wells Fargo | → $140 | Upgrades | Underweight → Equal-Weight |
| 10/12/2022 | 9.14% | UBS | $159 → $130 | Maintains | Neutral |
| 09/09/2022 | 38.53% | JP Morgan | $162 → $165 | Upgrades | Underweight → Neutral |
| 08/02/2022 | 33.49% | UBS | $149 → $159 | Maintains | Neutral |
| 07/18/2022 | 27.61% | Wells Fargo | $139 → $152 | Maintains | Underweight |
| 07/18/2022 | 31.81% | Barclays | $172 → $157 | Maintains | Equal-Weight |
| 06/24/2022 | — | Janney Montgomery Scott | Upgrades | Neutral → Buy | |
| 04/28/2022 | 46.92% | CFRA | $160 → $175 | Maintains | Hold |
| 04/28/2022 | 31.81% | UBS | $165 → $157 | Maintains | Neutral |
| 04/28/2022 | 26.77% | Wells Fargo | $156 → $151 | Maintains | Underweight |
| 04/20/2022 | 44.4% | Barclays | $166 → $172 | Maintains | Equal-Weight |
| 04/19/2022 | 30.97% | Wells Fargo | $148 → $156 | Maintains | Underweight |
| 02/23/2022 | 52.8% | HSBC | $190 → $182 | Upgrades | Hold → Buy |
| 02/17/2022 | 27.61% | UBS | $161 → $152 | Maintains | Neutral |
| 02/09/2022 | 39.37% | Barclays | $187 → $166 | Maintains | Equal-Weight |
| 02/07/2022 | 35.17% | UBS | $164 → $161 | Upgrades | Sell → Neutral |
| 01/19/2022 | 36.01% | Wells Fargo | $170 → $162 | Maintains | Underweight |
| 01/07/2022 | 43.56% | JP Morgan | $172 → $171 | Downgrades | Neutral → Underweight |
| 01/05/2022 | 47.76% | UBS | $185 → $176 | Downgrades | Neutral → Sell |
| 12/17/2021 | 55.32% | UBS | $177 → $185 | Maintains | Neutral |
| 12/08/2021 | 57% | Barclays | $174 → $187 | Maintains | Equal-Weight |
| 12/01/2021 | 42.73% | Wells Fargo | → $170 | Downgrades | Equal-Weight → Underweight |
| 11/04/2021 | 48.6% | Goldman Sachs | $191 → $177 | Downgrades | Buy → Neutral |
| 09/27/2021 | 49.44% | B of A Securities | → $178 | Downgrades | Neutral → Underperform |
| 09/01/2021 | 59.52% | HSBC | $181 → $190 | Downgrades | Buy → Hold |
| 08/06/2021 | 72.11% | Argus Research | → $205 | Upgrades | Hold → Buy |
| 08/04/2021 | 51.96% | Janney Montgomery Scott | $159 → $181 | Downgrades | Buy → Neutral |
| 07/15/2021 | 46.08% | Barclays | $170 → $174 | Maintains | Equal-Weight |
| 05/25/2021 | 42.73% | Barclays | $154 → $170 | Maintains | Equal-Weight |
| 05/12/2021 | — | Argus Research | Downgrades | Buy → Hold | |
| 03/19/2021 | 34.33% | Argus Research | $185 → $160 | Maintains | Buy |
| 03/10/2021 | 29.29% | Barclays | $184 → $154 | Maintains | Equal-Weight |
| 03/04/2021 | 33.49% | Janney Montgomery Scott | → $159 | Upgrades | Neutral → Buy |
| 01/22/2021 | 54.48% | Barclays | $173 → $184 | Maintains | Equal-Weight |
| 01/07/2021 | — | Atlantic Equities | Initiates Coverage On | → Overweight | |
| 11/10/2020 | 55.32% | Argus Research | $170 → $185 | Maintains | Buy |
| 10/13/2020 | — | Janney Montgomery Scott | Downgrades | Buy → Neutral | |
| 08/28/2020 | 19.22% | HSBC | → $142 | Downgrades | Buy → Hold |
| 08/12/2020 | 31.81% | Goldman Sachs | $146 → $157 | Maintains | Buy |
| 08/06/2020 | — | CFRA | Upgrades | Sell → Hold | |
| 08/06/2020 | 25.93% | Baird | $139 → $150 | Maintains | Outperform |
| 07/15/2020 | 15.86% | Barclays | → $138 | Initiates Coverage On | → Equal-Weight |
| 06/05/2020 | 16.7% | UBS | $127 → $139 | Maintains | Neutral |
| 05/07/2020 | -6.81% | CFRA | $131 → $111 | Maintains | Sell |
| 04/24/2020 | 18.38% | RBC Capital | → $141 | Initiates Coverage On | → Outperform |
| 04/16/2020 | 22.58% | Goldman Sachs | → $146 | Upgrades | Neutral → Buy |
| 03/16/2020 | 6.62% | UBS | $148 → $127 | Maintains | Neutral |
| 02/20/2020 | 34.33% | Argus Research | $140 → $160 | Maintains | Buy |
| 02/20/2020 | 16.7% | Baird | $128 → $139 | Maintains | Outperform |
| 02/20/2020 | 23.42% | Wells Fargo | $128 → $147 | Maintains | Equal-Weight |
| 02/04/2020 | 24.25% | UBS | $133 → $148 | Downgrades | Buy → Neutral |
| 12/12/2019 | 8.3% | JP Morgan | $127 → $129 | Maintains | Neutral |
| 11/15/2019 | 6.62% | JP Morgan | → $127 | Initiates Coverage On | → Neutral |
| 10/02/2019 | 7.46% | Baird | $117 → $128 | Maintains | Outperform |
| 08/14/2019 | 7.46% | Wells Fargo | $122 → $128 | Maintains | Market Perform |
| 07/15/2019 | — | B of A Securities | Downgrades | Neutral → Underperform | |
| 05/02/2019 | 1.59% | Janney Montgomery Scott | $102 → $121 | Maintains | Buy |
| 05/02/2019 | -7.65% | Baird | $104 → $110 | Maintains | Outperform |
| 03/27/2019 | -6.81% | Wells Fargo | → $111 | Downgrades | Outperform → Market Perform |
| 03/11/2019 | -4.29% | UBS | $111 → $114 | Maintains | Buy |
| 02/21/2019 | -13.53% | B of A Securities | $92 → $103 | Reiterates | Neutral → Neutral |
| 02/21/2019 | -8.49% | Wells Fargo | $101 → $109 | Maintains | Outperform |
| 12/12/2018 | -12.69% | Wells Fargo | $97 → $104 | Maintains | Outperform |
| 12/12/2018 | -12.69% | Baird | $103 → $104 | Maintains | Outperform |
| 12/06/2018 | -13.53% | Baird | → $103 | Upgrades | Neutral → Outperform |
| 10/18/2018 | -15.2% | UBS | $102 → $101 | Maintains | Buy |
What is the target price for American Water Works (AWK)?
The latest price target for American Water Works (NYSE: AWK) was reported by Mizuho on October 3, 2023. The analyst firm set a price target for $134.00 expecting AWK to rise to within 12 months (a possible 12.50% upside). 14 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for American Water Works (AWK)?
The latest analyst rating for American Water Works (NYSE: AWK) was provided by Mizuho, and American Water Works initiated their buy rating.
When is the next analyst rating going to be posted or updated for American Water Works (AWK)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of American Water Works, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for American Water Works was filed on October 3, 2023 so you should expect the next rating to be made available sometime around October 3, 2024.
Is the Analyst Rating American Water Works (AWK) correct?
While ratings are subjective and will change, the latest American Water Works (AWK) rating was a initiated with a price target of $0.00 to $134.00. The current price American Water Works (AWK) is trading at is $119.11, which is within the analyst's predicted range.